BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10705877)

  • 1. p53 mutation and mitotic infidelity.
    Tarapore P; Fukasawa K
    Cancer Invest; 2000; 18(2):148-55. PubMed ID: 10705877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrosome amplification, chromosome instability and cancer development.
    Fukasawa K
    Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
    Lingle WL; Lukasiewicz K; Salisbury JL
    Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal centrosome amplification in the absence of p53.
    Fukasawa K; Choi T; Kuriyama R; Rulong S; Vande Woude GF
    Science; 1996 Mar; 271(5256):1744-7. PubMed ID: 8596939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.
    Li JJ; Li SA
    Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.
    Haruki N; Harano T; Masuda A; Kiyono T; Takahashi T; Tatematsu Y; Shimizu S; Mitsudomi T; Konishi H; Osada H; Fujii Y; Takahashi T
    Am J Pathol; 2001 Oct; 159(4):1345-52. PubMed ID: 11583962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis.
    Capo-Chichi CD; Yeasky TM; Smith ER; Xu XX
    BMC Cell Biol; 2016 Nov; 17(1):37. PubMed ID: 27875985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 and centrosome hyperamplification.
    Tarapore P; Fukasawa K
    Oncogene; 2002 Sep; 21(40):6234-40. PubMed ID: 12214254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
    Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
    Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneuploidy and malignancy: an unsolved equation.
    Dey P
    J Clin Pathol; 2004 Dec; 57(12):1245-9. PubMed ID: 15563660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrosome amplification drives chromosomal instability in breast tumor development.
    Lingle WL; Barrett SL; Negron VC; D'Assoro AB; Boeneman K; Liu W; Whitehead CM; Reynolds C; Salisbury JL
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1978-83. PubMed ID: 11830638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities.
    Al-Romaih K; Bayani J; Vorobyova J; Karaskova J; Park PC; Zielenska M; Squire JA
    Cancer Genet Cytogenet; 2003 Jul; 144(2):91-9. PubMed ID: 12850370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic slippage underlies the relationship between p53 dysfunction and the induction of large micronuclei by colcemid.
    Hashimoto K; Todo T
    Mutagenesis; 2013 Jul; 28(4):457-64. PubMed ID: 23702691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes and tumour suppressors take on centrosomes.
    Fukasawa K
    Nat Rev Cancer; 2007 Dec; 7(12):911-24. PubMed ID: 18004399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tobacco carcinogen NNK disturbs mitotic chromosome alignment by interrupting p53 targeting to the centrosome.
    Park JE; Jang YL; Jang CY
    Toxicol Lett; 2017 Nov; 281():110-118. PubMed ID: 28964810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mitotic kinases in coupling the centrosome cycle with the assembly of the mitotic spindle.
    Wang G; Jiang Q; Zhang C
    J Cell Sci; 2014 Oct; 127(Pt 19):4111-22. PubMed ID: 25128564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1.
    Oikawa T; Okuda M; Ma Z; Goorha R; Tsujimoto H; Inokuma H; Fukasawa K
    Mol Cell Biol; 2005 May; 25(10):4046-61. PubMed ID: 15870277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneuploidy and cancer.
    Sen S
    Curr Opin Oncol; 2000 Jan; 12(1):82-8. PubMed ID: 10687734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells.
    Borel F; Lohez OD; Lacroix FB; Margolis RL
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9819-24. PubMed ID: 12119403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies.
    Liu X; Zheng H; Li X; Wang S; Meyerson HJ; Yang W; Neel BG; Qu CK
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):984-9. PubMed ID: 26755576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.